Ecuador vs Eswatini: New cases tested for RR-/MDR-TB
Ecuador
100.0%
in 2024
Eswatini
100.0%
in 2024
Ecuador rank
1st
Eswatini rank
1st
New cases tested for RR-/MDR-TB over time
- Ecuador
- Eswatini
How they compare
Ecuador currently reports 100.0% against 100.0% in Eswatini, a difference of 0.0%.
The two have swapped places 3 times across 12 shared years of data; in 2007 it was Ecuador ahead.
Ecuador ranks 1st and Eswatini ranks 1st of 192 countries.
Eswatini has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.5% | 4.8% | 1.2% | Eswatini |
| 2010s | 19.3% | 54.8% | 35.5% | Eswatini |
| 2020s | 95.8% | 100.0% | 4.2% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Ecuador or Eswatini?
- Ecuador, at 100.0% against 100.0% in Eswatini as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Ecuador and Eswatini?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Eswatini?
- 12 years are reported by both, from 2007 to 2024.
- How do Ecuador and Eswatini rank globally for new cases tested for rr-/mdr-tb?
- Ecuador ranks 1st and Eswatini ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.